AHMEDABAD: The central government on Monday told the Gujarat high court that it has planned allocation of 3.07 lakh vials of remdesivir to Gujarat, between April 21 and May 9.
In its affidavit filed in response to the HC’s query in the suo motu PIL on Covid-19, the Centre stated that its supply between April 21 and May 9 would be 3.07 lakh remdesivir vials from all seven manufacturers. The state government had last week demanded 4 lakh more vials after the central government decided to allocate the drug to states centrally on April 21.
The centre also stated that it is to import 4.5 lakh remdesivir vials from Gilead Sciences Inc of the US and Eva Pharma from Egypt in the near future to meet the increasing demand.
The central government also supplied information regarding the allocation of oxygen to Gujarat. It said that on April 26, the state of Gujarat lifted 904 MT of oxygen of the allocated 975 MT, against the Centre’s estimated requirement of 1,000 MT. The state has a production capacity of 847 MT, the central government said.
Regarding the increasing oxygen demand in Gujarat, the Centre has projected an increase in active Covid cases from 1.33 lakh on April 28 to 1.72 lakh on May 5. With this, the oxygen requirement will also increase from 301.06 MT to 505.12 MT for patients occupying 29,247 oxygen and 5,161 ICU beds in hospitals across the state.
To meet the increasing demands, the Centre has laid down plans on a war footing to send seven naval ships to transport consignments of the gas, and to commission 500 more pressure swing adsorption (PSA) oxygen plants at hospitals across the country in the near future.